Mometasone Furoate
34 NDCs across 10 manufacturers|24 Generic,10 Brand
Mometasone Furoate is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses and pruritus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 30, 1987, and the first generic was approved Mar 18, 2002. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $54 million on Mometasone Furoate across 1.1 million claims for 545,000 beneficiaries.
Mometasone Furoate is available as 34 NDCs from 10 manufacturers (24 generic, 10 brand), with NADAC prices from $0.21 to $8.67 per GM — the most expensive product costs about 42× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
34
24G / 10B
Manufacturers
10
competing in market
Price Spread
$0.21 – $8.67
per GM, 18 of 34 NDCs
7d Activity
avg -0.1% WoW · of 34 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Organon LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Corticosteroid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing MOMETASONE FUROATE(1 pricing outlier)
Frequently Asked Questions
What is Mometasone Furoate used to treat?
Mometasone Furoate is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses and pruritus, per the National Library of Medicine's MED-RT classification.
When did Mometasone Furoate become available as a generic?
FDA approved the first generic Mometasone Furoate (ANDA) on Mar 18, 2002. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Mometasone Furoate?
In 2024, Medicare Part D spent $54 million on Mometasone Furoate across 1.1 million claims for 545,000 beneficiaries.
How many Mometasone Furoate products are on the market?
The Mometasone Furoate drug market contains 34 NDCs from 10 manufacturers — 24 generic and 10 brand products.
What is the price range for Mometasone Furoate?
NADAC reference prices for Mometasone Furoate range from $0.2077 to $8.6678 per GM — the most expensive product costs about 42× the cheapest. 16 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Mometasone Furoate cheaper than brand?
The average generic NADAC for Mometasone Furoate is $0.3839 per GM, versus $7.6278 for brand-labeled products — brand versions average about 20× the generic price.
Which manufacturers make Mometasone Furoate?
10 manufacturers list Mometasone Furoate in NADAC. Ranked by number of NDCs, the largest are Organon LLC (8), Padagis Israel Pharmaceuticals Ltd (6), Glenmark Pharmaceuticals Inc., USA (6), Cosette Pharmaceuticals, Inc. (4), L. Perrigo Company (2).
How has the price of Mometasone Furoate changed recently?
Over the past 7 days, 7 Mometasone Furoate NDCs rose and 16 fell, with a market-wide average change of -0.1%.